Pharmaceuticals, Biotechnology and Life Sciences
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Bruce Given, M.D., Arrowhead’s chief operating officer and head of…
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to…
Extended Duration Formulation Ensures Cats Receive Broad-Spectrum Parasite Coverage in One Topical Application MADISON, N.J.–(BUSINESS WIRE)–$MRK #AnimalHealth–Merck Animal Health, a…
DUBLIN–(BUSINESS WIRE)–The “Osphena – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Osphena – Drug Insight, 2019 highlights…
FETROJA is the first approved antibiotic that functions as a siderophore FETROJA binds to free iron to gain additional cell…
FDA Accepts New Drug Application for Veverimer Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc.…
– New findings in human sensory neurons highlight role of IL-13 in amplifying itch and lebrikizumab’s role in inhibiting itch…
GUILFORD, Conn.–(BUSINESS WIRE)–Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug…
Interim data from Phase 1 study in patients with Ewing sarcoma show TK216 has been generally well tolerated One of…